Table 1.

Clinical and laboratory findings of all patients.

Year	Age (Years)/and Sex	Area	Drug	Received PD or Not	Effluent TG (mg/dL)	Time to Develop (h)	Time to Recovery (h)	Rechallenge Test	Reference
1993	39/2M, 3F	Japan	Manidipine	Yes	13,26,12,13,32 20 ± 9	24	<24	1 performed	[4]
1998	7M, 7F	Japan	Manidipine, Benidipine, Nisoldipine, Nifedipine	Yes	NM	48	NM (Shortly)	2 performed	[5]
1999	43F	Japan	Manidipine	No (renal dysfunction)	81	192	288	Not performed	[6]
2006	NM	Turkey	Lercanidipine	Yes	NM	24	NM	NM	[7]
2008	52.6 ± 18.5, 5M, 3F	Taiwan	Lercanidipine	Yes	128.4 ± 133.0	NM	<24	2 performed	[8]
2009	41/F	Taiwan	Lercanidipine	Yes	251	72	16 h	Reproducible	[9]
2010	39.4 ± 14.3 4M/5F	Taiwan	Lercanidipine	Yes	19.3 ± 6.3	28.8	<24	2 performed	[10]
2010	76/M	Japan	Azelnidipine	No (renal dysfunction)	NM	48	NM	NM	[11]
2012	55/M	India	Diltiazem	Yes	55.6	NM	<24	Reproducible	[12]
2014	59/F	Spain	Lercanidipine	Yes	20	72	24	Reproducible	[13]
2016	65/M	India	Amlodipine	Yes	293.8	72	<24	Not performed	[3]
2017	80/F	Spain	Lercanidipine	No (renal dysfunction)	321	48	NM	Not performed	[2]
2017	64/F	Turkey	Lercanidipine	Yes	80	24	24	Not performed	[14]
2017	82/M	Taiwan	Lercanidipine	Yes	NM	72	24	Not performed	Our patient
All	Mean:50

NM = not mentioned; TG = triglyceride.